Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Antibody COVID-19 Therapies Back in China Spotlight Amid Infection Surge

Aug 13 2021

• By Dexter Jie Yan

China biotechs work on antibody COVID-19 therapies — Three China-based biotechs are still chasing antibody COVID-19 therapies • Source: Alamy

Related Content

US FDA Authorizes Lilly’s COVID-19 mAB Combo For Lower Doses Than Tested In Phase III

Feb 11 2021

Coronavirus Update: Regeneron's REGEN-COV Authorized For Prevention

Jul 30 2021

Wuhan Back In Spotlight As Delta Variant Highlights Booster Shots Urgency

Aug 06 2021

Related Companies

Regeneron Pharmaceuticals, Inc.

Shanghai Junshi Biosciences Co., Ltd.

Eli Lilly and Company

AbCellera Biologics Inc.

Bio-Thera Solutions Ltd.

I-Mab

Brii Biosciences

Additional Topics

China Asia Pacific Research & Development Coronavirus COVID-19 Companies BioPharmaceutical

More from China

More from Focus On Asia

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.